Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 5, 2004, Pages 883-889

  Satyanarayana, M ^a   Tiwari, Priti ^a   Tripathi, Brajendra K ^a   Srivastava, A K ^a   Pratap, Ram ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Aryloxypropanolamines and antihyperglycemic activity; Chalcones

Indexed keywords

2' (2 HYDROXY 3 ISOPROPYLAMINOPROPOXY) 4 METHOXYCHALCONE; 3' (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 4 METHOXYCHALCONE; 3,4 DIMETHOXY 4' [2 HYDROXY 3 (4 PHENYLPIPERAZIN 1 YL)PROPOXYL]CHALCONE; 4' (3 ISOBUTYLAMINO 2 HYDROXYPROPOXY) 3,4 METHYLENEDIOXYCHALCONE; 4' (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 3,4 METHYLENEDIOXYCHALCONE; 4' [2 HYDROXY 3 [4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]PROPOXYL] 4 METHOXYCHALCONE; CHALCONE DERIVATIVE; GLIBENCLAMIDE; GLUCOSE; METFORMIN; PROPANOLAMINE DERIVATIVE; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 1342300735     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.12.026     Document Type: Article

References (26)

1. Bennett P.H. Diabet. Metab. Rev. 13:1997;583.
2. Ginsberg H., Plutzky J., Sobel E. J. Cardiovasc. Risk. 6:1999;337.
3. Ruderman N.B., Schneider S.H. Diabetes Care. 15(suppl. 4):1992;1787.
4. Kumar S., Boulton A.J.M., Beck-Nielsen H., Berthezene F., Mugge M., Pearson B., Spinas G.A., Donoghue S., Lettis S., Stewart-Long P. Diabetalogia. 30:1996;701.
5. Saleh Y.M. Diabetes Rev. 7:1999;55.
6. Arch J.R.S. Proc. Nutr. Soc. 48:1989;215.
7. 3-adrenergic agonism; Futura publishing: Armonk 1995.
8. Leo, A.; Muller, M. Eur. Patent Appl. EP 14023, 1985; Chem. Abstr. 1986, 104, 68565.
9. Holloway, B. R.; Howe, R.; Rao, B. S.; Stribling, D. Eur. Patent Appl. EP 210849, 1987; Chem. Abstr. 1987, 106, 138082.
10. Bloom J.D., Dutia M.D., Johson B.D., Wissner A., Burns M.G., Largis E.E., Dolan J.A., Claus T.H. J. Med. Chem. 35:1992;3081.
11. Fisher M.H., Amend A.M., Bach T.J. J. Clin. Invest. 101:1998;2387.
12. John Anto R., Sukumaran K., Kuttan G., Rao M.N.A., Subbaraju V., Kuttan R. Cancer Letters. 97:1995;33.
13. Vaya J., Belinky P.A., Aviram M. Free Radic. Biol. Med. 23:1997;302.
14. Mukherjee S., Kumar V., Prasad A.K., Raj H.G., Bracke M.E., Olsen C.E., Jain S.C., Parmar V.P. Bioorg. Med. Chem. 9:2001;337.
15. Indyah S.A., Timmerman H., Samhoedi M., Sastrohami D., Sugiyanto H., Van Der Goot H. Eur. J. Med. Chem. 35:2000;449.
16. Chen M., Christensen S.B., Zhai L., Rasmussen M.H., Theander T.G., Frokjaer S., Steffensen B., Davidson J., Kharazmi A. J. Infect. Dis. 176:1997;1327.
17. Nielsen S.F., Christensen S.B., Cruciani G., Kharazmi A., Liljefors T. J. Med. Chem. 41:1998;4819.
18. Hsin-kaw H., Tai-Hua L., PyangWang J., Jeh-Jeng W., Chun-Nan L. Pharma. Res. 15:1998;39.
19. Kumar S.K., Hager E., Catherine P., Gurulingappa H., Davidson N.E., Khan S.R. J. Med. Chem. 46:2003;2813.
20. Rong Min C., Li Hong H., Tian Ying A., Jia L., Qiang S. Bioorg. Med. Chem. Lett. 12:2002;3387.
21. Severi F., Benvenuti S., Constantino L.C., Vampa G., Antolini L. Eur. J. Med. Chem. 3:1998;859.
22. Faure P., Rossini E., Lafond J., Richard M.J., Savier A., Halini S. J. Nutr. 127:1997;103.
23. Sogawa S., Nihro Y., Ueda H., Izumi A., Miki T., Matsumosa H., Satoh T. J. Med. Chem. 36:1993;3904.
24. Ram V.J., Farhanullah, Tripathi B.K., Srivastava A.K. Bioorg. Med. Chem. 11:2003;2439.
25. Buckingham, J. Dictionary of Natural Products; Ed. Chapman and Hall: 1994, Vol. 2, D-F, pp 1574, D-01615.
26. Dhar D.N. J. Ind. Chem. Soc. 38:1961;823.